Pancreatic Cancer Research

ResearcherHammersmith HospitalActive in the last 2 years

Tamara Gall

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3972-268X; OpenAlex author ID A5031000713. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2013: 5 papers · 2014: 3 papers · 2015: 3 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 15

  1. Impact of social deprivation upon the preoperative pathway and early surgical outcomes after pancreatoduodenectomy for PDAC and non-PDAC periampullary cancer i… Co-author DOI 10.1016/j.hpb.2025.07.007↗
  2. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.ajpath.2018.03.020↗
  3. Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma? Co-author DOI 10.18632/oncotarget.26511↗
  4. Predicting disease recurrence in pancreatic ductal adenocarcinoma Co-author DOI 10.25560/41847↗
  5. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis. Co-author DOI 10.1016/j.ejca.2015.04.006↗
  6. Pancreatic cancer: current understanding of molecular and genetic aetiologies. Co-author DOI 10.1136/postgradmedj-2014-133161↗
  7. Pancreatic cancer: current management and treatment strategies. Co-author DOI 10.1136/postgradmedj-2014-133222↗
  8. Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. Co-author DOI 10.1001/jamasurg.2013.3643↗
  9. A microRNA meta-signature for pancreatic ductal adenocarcinoma. Co-author DOI 10.1586/14737159.2014.893192↗
  10. Surgical techniques for improving outcomes in pancreatic ductal adenocarcinoma. Co-author DOI 10.1586/17474124.2014.881251↗
  11. Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker? Co-author DOI 10.1586/14737159.2013.845091↗
  12. Towards a clinical use of miRNAs in pancreatic cancer biopsies. First author DOI 10.1586/erm.12.136↗
  13. Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer. Co-author DOI 10.1586/erm.13.31↗
  14. Is there a 'margin' for error in pancreatic cancer surgery? First author DOI 10.2217/fon.12.175↗
  15. Circulating molecular markers in pancreatic cancer: ready for clinical use? Co-author DOI 10.2217/fon.12.187↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Long R. Jiao · 12 shared papers, 2013–2019 · strength 0.73
  2. Adam Enver Frampton · 11 shared papers, 2013–2019 · strength 0.62
  3. Leandro Castellano · 7 shared papers, 2013–2019 · strength 0.36
  4. Jonathan Krell · 8 shared papers, 2013–2015 · strength 0.35
  5. Justin Stebbing · 6 shared papers, 2013–2015 · strength 0.26
  6. Harpreet Singh Wasan · 2 shared papers, 2015 · strength 0.16
  7. Nagy Adley Habib · 2 shared papers, 2015–2019 · strength 0.14
  8. Duncan R.C. Spalding · 1 shared paper, 2019 · strength 0.09
  9. Nigel Balfour Jamieson · 2 shared papers, 2014–2015 · strength 0.09
  10. Elisa Giovannetti · 2 shared papers, 2014–2015 · strength 0.09
  11. Mikael Hans Sodergren · 1 shared paper, 2014 · strength 0.05
  12. Niccola Funel · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.